This event was detected in one FUS-KLF17-translocated ME tumor and in one ME negative for fusion transcripts involving either EWSR1 or FUS, both lacking pathological evidence of malignancy according to the criteria outlined in Jo et al [1]. The gene discussed is FUS; the disease is neoplasm.